Inflammation-related colorectal cancer may be accelerated by Hrh2, Hrh3, and Hrh4, according to Clobenpropit, an Hrh3 antagonist and Hrh4 receptor agonist. This evidence concerns the gene HRH3 and colorectal cancer.